JinMatrix has ranked among the top searched stocks for 6 days in the past month.
As of 2:30 PM on the 23rd, JinMatrix is trading at 31,350 KRW, up 1.13% from the previous day. This represents a 95.33% increase compared to November 4. JinMatrix is known as a specialized company developing diagnostic agents through biotechnology research.
Over the past 5 days, individual investors have net purchased 350,490 shares, while foreigners and institutions have net purchased 11,068 shares and net sold 171,922 shares, respectively.
On November 20, JinMatrix became a market issue with the headline "AstraZeneca COVID-19 vaccine shows strong efficacy in all adults."

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
